Press Release

GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference

Aug 07, 2018 at 4:05 PM EDT

SOUTH SAN FRANCISCO, Calif. , Aug. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2018 Wedbush PacGrow Healthcare Conference in New York City on Tuesday, August 14 at 10:20 a.m. Eastern Time.

The presentation will be webcast live and available for replay from GBT’s website at in the Investors section.

About GBT
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit and follow the company on Twitter @GBT_news.

Contact Information:
Myesha Lacy (investors)

Julie Normart (media)

Primary Logo

Global Blood Therapeutics, Inc.